Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...

SEOUL, South Korea, Dec. 9, 2025 /PRNewswire/ -- MUTE-Seq is a new liquid-biopsy method powered by an engineered ultra-precise CRISPR enzyme, FnCas9-AF2, which can distinguish single-base mismatches ...

Precision medicine in endometrial cancer emphasizes molecular drivers, challenging traditional histopathologic approaches and ...

New Bridge Capture method offers advances for clinical testing, disease monitoring and treatment selection.

High-frequency ultrasound (HFUS) has emerged as a valuable non-invasive imaging modality in dermatology, offering detailed visualisation of the skin’s layers and its pathologies. Its high resolution ...

Timing matters: Impact of early advance care planning conversations on hospice utilization in outpatient oncology. Advance care planning activities among a cohort of patients with metastatic breast ...

Combination therapies represent a promising frontier in cancer treatment, addressing the critical need to enhance efficacy ...

Anktiva, also known as nogapendekin alfa inbakicept, is a new cancer therapy that boosts the immune system to target cancer ...